ROME Therapeutics

ROME Therapeutics

Biotechnology Research Boston, Massachusetts, United States 36 employees
Employees
36
Contacts
3
Emails
3
Phones
1

ROME Therapeutics Overview

Headquarters
Boston, Massachusetts, United States
Website
rometx.com
Industry
Biotechnology Research
Employees
36
Founded
2020
Funding
72.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About ROME Therapeutics

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning. ROME was launched in April 2020 and was incubated at GV, in collaboration with ARCH Venture Partners and Partners Innovation Fund. ROME is based in Cambridge, Mass. For more information, please visit www.rometx.com.

ROME Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

ROME Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Rosana Kapeller
Email Phone
Jeb Keiper Former Chief Executive Officer
View
Shon Pulley, Ph.d. Principal and Owner at Solterra
Email
David Ting
Email

Employees by Management Level

Individual contributor 5 profiles
Senior / Lead 3 profiles
Executive 2 profiles
Director 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 4 4 2
Operations 1 1 0
IT 1 1 0

ROME Therapeutics Tech Stack

Data / AI 5 profiles

Compare Similar Companies to ROME Therapeutics